0.00Open0.50Pre Close0 Volume3 Open Interest61.00Strike Price0.00Turnover7462.63%IV24.16%PremiumDec 27, 2024Expiry Date0.00Intrinsic Value100Multiplier-5DDays to Expiry0.50Extrinsic Value100Contract SizeAmericanOptions Type-0.0668Delta0.0082Gamma159.54Leverage Ratio-394.0157Theta0.0000Rho-10.66Eff Leverage0.0003Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet